2 unchanged sentences
Rule 10b5-1 Trading Plans
−Removed: During the three months ended March 31, 2025, none of our directors or officers adopted , materially modified , or terminated any contract, instruction, or written plan for the purchase or sale of our securities that was intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act or any non-Rule 10b5-1 trading arrangement.
+Added: During the three months ended June 30, 2025 , none of our directors or officers adopted , materially modified , or terminated any contract, instruction, or written plan for the purchase or sale of our securities that was intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act or any non-Rule 10b5-1 trading arrangement.
+Added: Departure of Directors or Certain Officers
+Added: On August 4, 2025, Brian Adams informed the company's Board of Directors that he is resigning from his position as the Company's Chief Legal Officer and Secretary, effective as of August 8, 2025.
+Added: Adams' resignation is not the result of any dispute or disagreement with the company.
+Added: Adams will not receive any severance payments or benefits in connection with his departure.
+Added: To enable a smooth transition, Mr.
+Added: Adams has agreed to provide ad hoc transition support to the company for no additional cash compensation.
Fourth Amended and Restated Certificate of Incorporation of Relay Therapeutics, Inc.
4 unchanged sentences
001-39385) filed on July 21, 2020).
+Added: Amended and Restated Non-Employee Director Compensation Policy, effective as of May 8, 2025
+Added: Third Amendment to Lease, dated as of June 3, 2025, between the Registrant and ARE-MA REGION NO.
Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) or 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
8 unchanged sentences
Such certifications will not be deemed to be incorporated by reference into any filings under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, except to the extent that the Registrant specifically incorporates it by reference.
+Added: # Indicates a management contract or any compensatory plan, contract, or arrangement.
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
RELAY THERAPEUTICS, INC.
+Added: August 7, 2025
/S/ SANJIV K.
1 unchanged sentence
(Principal Executive Officer)
+Added: August 7, 2025
/S/ THOMAS CATINAZZO
3 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.